Genomic Prediction: Kelly Ketterson

Genomic Prediction, a provider of human embryo genetic testing, has promoted Kelly Ketterson to the position of CEO. Ketterson has served as COO of the company since January. Prior to Genomic Prediction, Ketterson was VP of operations and VP of medical affairs at CooperSurgical, where she launched the CooperSurgical US Center of Excellence. Ketterson also previously serves as chief operating officer at Reprogenetics and executive director of Tyho-Galileo Research Laboratories.